56 completed, 6 terminated, 5 unknown, 4 withdrawn. 28 Phase 4, 25 Phase 3, 10 Phase 2, 3 Not applicable, 2 Phase 1.
Follow Ibandronic Acid: new trials by email Literature Review of Ibandronic Acid trials Research Report on Ibandronic Acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases Zanzalintinib, Investigator Choice of Bone Strengthening Agents (BSA), Non-Investigational Radiation Therapy (RT) - Clear Cell Renal Cell Cancer (ccRCC), Clear Cell Renal Carcinoma | Phase 2 | Recruiting | Kelly Fitzgerald, MD | 20 | 2026-06-10 | 2026-07-27 |
| Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis Alendronate, Ibandronate; Risedronate, Teriparatide - Osteoporosis, Osteoporosis, Postmenopausal | Not applicable | Completed | Khyber Medical University Peshawar | 40 | 2025-10-01 | 2026-08-13 |
| Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy. Ibandronate, Calcium, Vitamin D3 - Hepatic Osteodystrophy, Liver Cirrhosis | Not applicable | Unknown | Institute of Liver and Biliary Sciences, India | 80 | 2023-09-01 | 2023-09-01 |
| Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate Coral Complex 3, Ibandronate, Vitamin D3 - Osteoporosis, Postmenopausal | Phase 2 | Completed | Columbia University | 60 | 2020-02-05 | 2024-05-09 |
| Use of Ibandronate in Diabetic Patients Ibandronate Oral Tablet - Osteoporosis, Postmenopausal, Type 2 Diabetes | Not applicable | Completed | Yeouido St. Mary's Hospital | 121 | 2018-10-01 | 2022-03-04 |
| Efficacy of Oral Ibandronate in Osteoporosis Ibandronate, Oral Ibandronate and Vitamin D - Osteoporosis | Phase 2 | Unknown | Shinshu University | 100 | 2017-10-12 | 2021-09-21 |
| Exome Sequencing for Atypical Femoral Fractures Bisphosphonate - Atypical Femoral Fractures, Osteoporosis | Completed | Washington University School of Medicine | 38 | 2016-04-01 | 2018-12-31 | |
| Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis ibandronate, Placebo - Aseptic Hip Necrosis, Hip Necrosis | Phase 3 | Terminated | Brigitte Jolles, MD | 8 | 2014-06-01 | 2017-05-17 |
| Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation Treated with Ibandronic acid as per protocol - Cirrhosis | Phase 4 | Completed | Dr. Ashish Kumar | 47 | 2012-08-01 | 2014-09-26 |
| Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis Test group, Reference group - Postmenopausal Women With Osteoporosis | Phase 3 | Completed | Alvogen Korea | 201 | 2011-12-01 | 2016-11-01 |
| Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers bonviva - Healthy | Phase 1 | Completed | Alvogen Korea | 105 | 2011-08-01 | 2016-11-01 |
| A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis ibandronate [Bonviva/Boniva] - Post Menopausal Osteoporosis | Phase 3 | Completed | Hoffmann-La Roche | 41 | 2011-04-01 | 2015-08-13 |
| Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase Inhibitors Ibandronic acid, Placebo - Breast Cancer | Phase 2 | Completed | Azienda Ospedaliero-Universitaria Careggi | 171 | 2011-01-01 | 2019-10-22 |
| A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis alendronate, ibandronate [Bonviva/Boniva] - Postmenopausal Osteoporosis | Completed | Hoffmann-La Roche | 6054 | 2010-04-01 | 2016-11-02 | |
| Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids Ibandronate, Placebo - Rheumatoid Arthritis, Osteoporosis | Phase 4 | Completed | Yeong-Wook Song | 167 | 2010-04-01 | 2014-11-19 |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) Alendronate, Etidronate, Ibandronate - Esophageal Cancer, Squamous Cell Carcinoma | Completed | Organon and Co | 684815 | 2010-02-26 | 2022-02-03 | |
| A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates Ibandronate, Denosumab - Postmenopausal Osteoporosis | Phase 3 | Completed | Amgen | 833 | 2009-07-01 | 2013-02-11 |
| Observational Study of iv Ibandronate in Women With Postmenopausal Osteoporosis Ibandronic acid - Osteoporosis | Completed | Clinic of Endocrinology and Metabolic Disorders, Macedonia | 700 | 2009-03-01 | 2014-10-22 | |
| Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients Ibandronate, Vitamin Supplements - Hematological Malignancies | Phase 3 | Completed | M.D. Anderson Cancer Center | 78 | 2008-12-09 | 2018-09-13 |
| S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307 clodronate disodium, demeclocycline hydrochloride, ibandronate sodium - Breast Cancer | Withdrawn | SWOG Cancer Research Network | 2008-10-01 | 2013-04-10 |
Showing 20 of 73. Sign in to see all of them.
Osteoporosis, Postmenopausal (28) · Osteoporosis (18) · Neoplasm Metastasis (12) · Pain (10) · Bone Neoplasms (8) · Breast Neoplasms (7) · Bone Diseases, Metabolic (2) · Humoral Hypercalcemia Of Malignancy (2) · Adenocarcinoma (1) · Arthritis, Rheumatoid (1) · Breast Neoplasms, Male (1) · Carcinoma, Renal Cell (1) · Carcinoma, Squamous Cell (1) · Clear-cell metastatic renal cell carcinoma (1) · Diabetes Mellitus, Type 2 (1)
Hoffmann-La Roche (34) · GlaxoSmithKline (4) · SWOG Cancer Research Network (3) · Alvogen Korea (2) · Organon and Co (2) · Amgen (1) · Azienda Ospedaliero-Universitaria Careggi (1) · Brigitte Jolles, MD (1) · Cancer Research UK (1) · Charite University, Berlin, Germany (1) · Chinese Society of Lung Cancer (1) · Chinese University of Hong Kong (1) · Chugai Pharmaceutical (1) · Clinic of Endocrinology and Metabolic Disorders, Macedonia (1) · Columbia University (1)
United States (21) · Germany (10) · France (9) · United Kingdom (9) · Hungary (8) · Italy (7) · Mexico (7) · Poland (7) · Belgium (6) · Australia (5) · Norway (5) · South Korea (5) · Spain (5) · Switzerland (5) · Czechia (4)
Dawn Hershman, MD (2) · Alec Walker, MD, DrPH (1) · Alexander H Paterson, MD, FRCP (1) · Angela Rogers, Dr (1) · Arshad Hussain, M.D Consultant (1) · Asma Mehmood, PhD Scholar (1) · Carla I. Falkson, MD (1) · Dennis M. Black, PhD (1) · Dieter Felsenberg, Prof. Dr. (1) · Dr. Simran Sethi, MBBS (1) · Edmund K Li, MD (1)
PMID 38979716, PMID 20964867, PMID 21703900, PMID 21975558, PMID 22791766, PMID 23589163, PMID 23812464, PMID 24332514, PMID 28161119, PMID 28274254, PMID 30648627, PMID 31776637, PMID 32929540, PMID 34037241, PMID 34231877, PMID 35410197, PMID 37797387, PMID 39588131
2005 (2), U10CA032102 (1), U10CA037429 (1)